AnaptysBio, Inc. (ANAB) Earnings
|
Expand Research on ANAB
| Next EPS Date | 8/24/26 | EPS Growth Rate | +79.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +0.8% | Revenue Growth Rate | -9.2% |
| Average % Move 1-Wk after EPS | -1.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/24/26  |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/21/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/19/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/17/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/13/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/12/26 |
Q226 | N/A | -$0.13 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 8/10/26 |
Q226 | N/A | -$0.28 | N/A | N/A | $20.22M | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | -$1.84 | -$0.96 | -$0.88 | $25.56M | $23.04M | N/A |  | | Details |
